<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Gutcher I</dc:creator>
  <dc:creator>Urich E</dc:creator>
  <dc:creator>Wolter K</dc:creator>
  <dc:creator>Prinz M</dc:creator>
  <dc:creator>Becher B</dc:creator>
  <dc:date>2006</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">T helper type 1 (T(H)1) lymphocytes are considered to be the main pathogenic cell type responsible for organ-specific autoimmune inflammation. As interleukin 18 (IL-18) is a cofactor with IL-12 in promoting T(H)1 cell development, we examined the function of IL-18 and its receptor, IL-18R, in autoimmune central nervous system inflammation. Similar to IL-12-deficient mice, IL-18-deficient mice were susceptible to experimental autoimmune encephalomyelitis. In contrast, IL-18R alpha-deficient mice were resistant to experimental autoimmune encephalomyelitis, indicating involvement of an IL-18R alpha ligand other than IL-18 with encephalitogenic properties. Moreover, engagement of IL-18R alpha on antigen-presenting cells was required for the generation of pathogenic IL-17-producing T helper cells. Thus, IL-18 and T(H)1 cells are dispensable, whereas IL-18R alpha and IL-17-producing T helper cells are required, for autoimmune central nervous system inflammation.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/75247</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1038/ni1377</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/16906165</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>Nature immunology. - 2006</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Antigen-Presenting Cells</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Antigens</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Encephalomyelitis, Autoimmune, Experimental</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Interleukin-12</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Interleukin-17</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Interleukin-18</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Interleukin-23</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Mice</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Mice, Knockout</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Mitogens</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Receptors, Interleukin-18</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Th1 Cells</dc:subject>
  <dc:title xmlns:ns14="xml" ns14:lang="en">Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
